ACA
Overvalued by 26.8% based on the discounted cash flow analysis.
Market cap | $4.21 Billion |
---|---|
Enterprise Value | $5.80 Billion |
Dividend Yield | $0.2 (0.231830300220239%) |
Earnings per Share | $1.92 |
Beta | 1 |
Outstanding Shares | 48,700,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 53.79 |
---|---|
PEG | -135.18 |
Price to Sales | 1.63 |
Price to Book Ratio | 1.73 |
Enterprise Value to Revenue | 2.23 |
Enterprise Value to EBIT | 37.07 |
Enterprise Value to Net Income | 74 |
Total Debt to Enterprise | 0.3 |
Debt to Equity | 0.72 |
No data
No data